Metabolic dysfunction‐associated steatotic liver disease and <scp>MetALD</scp> increases the risk of liver cancer and gastrointestinal cancer: A nationwide cohort study
This study showed that MASLD and MetALD are associated with an increased risk of cancer, particularly liver and gastrointestinal cancers. The findings build new evidence for the clinical outcomes of MetALD while highlighting the importance of managing alcohol intake properly in MASLD and MetALD.
Authors
- Gi‐Ae Kim (ORCID: https://orcid.org/0000-0002-5002-0822)
- Seungbong Han (ORCID: https://orcid.org/0000-0003-2938-8072)
- Jooyi Jung (ORCID: https://orcid.org/0000-0001-5312-5446)
- Yewan Park (ORCID: https://orcid.org/0000-0003-2560-7346)
Institutions
- Korea University (KR)
- Kyung Hee University (KR)
Publication Details
- Journal
- Alimentary Pharmacology & Therapeutics
- Published
- 2024-09-20
- DOI
- https://doi.org/10.1111/apt.18286
- Citations
- 28
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 10.83
Funders
- National Research Foundation
- Kyung Hee University
- National Research Foundation of Korea